FORUM
« NYSE's John Thain |
Hyman and Silver: "Medical Malpractice Litigation and Tort Reform: It's the Incentives, Stupid" »
November 12, 2006
Study: Naproxen has anticlotting effect similar to aspirin
Maggie Fox has the story for Reuters. You may recall that plaintiffs' lawyers have been dragging Merck over the coals for daring to suggest that a likely hypothesis for the statistically significant difference between Vioxx and naproxen in its VIGOR study was because of the cardioprotective effect of naproxen.
Posted by Ted Frank at 12:42 AM
| TrackBack (0)
|
categories:
Vioxx/Drug Litigation
|
|